Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the Board of Directors

    NEXT STORY
    Helix BioPharma Corp. Provides Corporate Update
    PREV STORY
    Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28, 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Granted Approval to Transition from the Biotech Chapter of the Hong Kong Stock Exchange to a General Listing

    author_avatar
    NASDAQ Market News

    TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

    Timely Enrollment Signifies Milestone in TRIOEDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Translational ...

    author_avatar
    NASDAQ Market News

    Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    author_avatar
    NASDAQ Market News